Clinical evidence of prevention strategies for capecitabine‐induced hand‐foot syndrome
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31269
Abstract: Hand‐foot syndrome (HFS) is the most common adverse effect of capecitabine‐containing chemotherapy. The purpose of this study was to assess the efficacies of various prevention and treatment strategies for capecitabine‐induced HFS. Searches of the PubMed… read more here.
Keywords: foot syndrome; capecitabine; induced hfs; strategies capecitabine ... See more keywords
A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-022-04411-9
Abstract: Sorafenib is an effective therapy for advanced hepatocellular carcinoma (HCC). Hand–foot syndrome (HFS) is a serious adverse effect associated with sorafenib therapy. This study aimed to develop an updated clinical prediction tool that allows personalized… read more here.
Keywords: tool; hepatocellular carcinoma; foot syndrome; prediction ... See more keywords
Diabetic Foot Syndrome in the Twenty-First Century.
Sign Up to like & getrecommendations! Published in 2019 at "Clinics in podiatric medicine and surgery"
DOI: 10.1016/j.cpm.2019.02.002
Abstract: Diabetes mellitus is an international epidemic. In the United States, the prevalence of diabetes has increased from estimates in 1990 when 6.5% of the population was affected and 6.2 million people had diabetes compared with… read more here.
Keywords: diabetic foot; foot; syndrome twenty; twenty first ... See more keywords
Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol
Sign Up to like & getrecommendations! Published in 2017 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2017.03.017
Abstract: INTRODUCTION Sorafenib is a multitargeted potent antiangiogenic tyrosine kinase inhibitor. Sorafenib has antiproliferative and antineoplastic effects in addition to antiangiogenic effects. According to research, the use of sorafenib is effective in the treatment of advanced… read more here.
Keywords: foot syndrome; hand foot; sorafenib;
Onychomycosis associated with diabetic foot syndrome: A systematic review
Sign Up to like & getrecommendations! Published in 2023 at "Mycoses"
DOI: 10.1111/myc.13577
Abstract: A systematic review was conducted to investigate the prevalence of onychomycosis in patients with diabetes. The association of onychomycosis with risk factors in patients with diabetic foot syndrome was also examined. read more here.
Keywords: foot syndrome; onychomycosis; diabetic foot; systematic review ... See more keywords
Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study
Sign Up to like & getrecommendations! Published in 2022 at "Integrative Cancer Therapies"
DOI: 10.1177/15347354221140402
Abstract: Purpose: Pegylated liposomal doxorubicin (PLD) is highly effective for treating multiple myeloma (MM). Hand-foot syndrome (HFS) is a dose-limiting adverse event of PLD that may reduce a patient’s quality of life or prevent certain patients… read more here.
Keywords: hand foot; pegylated liposomal; liposomal doxorubicin; foot syndrome ... See more keywords
Topical sildenafil in the treatment of hand-foot syndrome and hand-foot skin reaction: A retrospective study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e22095
Abstract: e22095Background: Hand-foot syndrome (HFS) and hand-foot skin reaction (HFSR) are painful, debilitating, and often dose-limiting complications of anticancer agents. These cutaneous reactions are en... read more here.
Keywords: foot skin; foot syndrome; skin reaction; hand ... See more keywords
Growth factors in the treatment of diabetic foot syndrome
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes mellitus"
DOI: 10.14341/dm10130
Abstract: Growth factors play a key role in wound healing, deficiency of which leads to delayed healing. Various growth factors are used in the treatment of chronic wounds, including diabetic foot ulcers. The purpose of this… read more here.
Keywords: foot syndrome; treatment; growth factors; growth ... See more keywords
Circulating Angiogenic Factors and Ischemic Diabetic Foot Syndrome Advancement—A Pilot Study
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11061559
Abstract: Despite clear evidence of inadequate angiogenesis in ischemic diabetic foot syndrome (DFS) pathogenesis, angiogenic factor level changes in patients with ischemic DFS remain inconsistent. This study aimed to assess circulating angiogenic factors concerning ischemic DFS… read more here.
Keywords: ischemic diabetic; diabetic foot; angiogenic factors; foot syndrome ... See more keywords
Relations between Interlukin-6 and Some Biochemical Parameters in Diabetic Foot Syndrome
Sign Up to like & getrecommendations! Published in 2021 at "Medico-Legal Update"
DOI: 10.37506/mlu.v21i1.2487
Abstract: The aim of this study is to predict the incidence of diabetic foot syndrome in type 2 diabetic patients bymeasuring some parameters (IL-6, FBS, MDA, CP, BMI). Samples were obtained from (75) type II diabeticpatients… read more here.
Keywords: diabetic patients; group; foot syndrome; diabetic foot ... See more keywords
Hand Foot Syndrome Has the Strongest Impact on QOL in Skin Toxicities of Chemotherapy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cancer"
DOI: 10.7150/jca.31059
Abstract: Background: Chemotherapy often results in dermatologic toxicities, which decrease quality of life (QOL) of cancer patients. These adverse skin reactions sometimes happen simultaneously. Though previous reports have demonstrated that skin reactions influence QOL, those reports… read more here.
Keywords: foot syndrome; hand foot; skin toxicity;